Sep 2026
[Sexual/intimate morbidity under tamoxifen and risk of weakened treatment adherence in premenopausal women with HR+ breast cancer: An underestimated and potentially modifiable factor].
Sexual/intimate morbidity associated with tamoxifen is an underestimated but modifiable factor that weakens treatment adherence and quality of life in premenopausal women with hormone-sensitive breast cancer.
Flora Ancelin, Pierre Bondil
· Bulletin du Cancer · 0 citations